European E. coli strain never seen before in humans, scientists say

NewsGuard 100/100 Score

The food safety office of the WHO on Thursday announced that the bacterium responsible for the E. coli outbreak in Europe is a strain never seen before in humans and could mean "the infection could prove unusually difficult to bring under control," Nature News reports (Turner, 6/2).

At least 16 people have died and 1,624 cases have been reported, according to the WHO, making it "the deadliest outbreak of the bacteria on record as a rare strain is causing kidney failure in unprecedented numbers, U.S. health officials said," Bloomberg reports (Randall/Larkin, 6/3).

"According to WHO, of more than 1,600 people sickened by this E. coli strain, 499 developed a rare and potentially fatal kidney-failure complication known as hemolytic uremic syndrome - a complication that can shut down the kidneys and normally occurs in only a small percentage of people sickened during an E. coli outbreak. It is also unusual in that most of those affected are young adults - and mostly women. E. coli infections normally hit young children and the elderly hardest," the Wall Street Journal writes (Martin/Stevens/Miller, 6/3).

The origins of the outbreak remain unknown, and "[t]en countries have now reported cases, but virtually all of them have been traced to northern Germany, where the outbreak began several weeks ago," according to the New York Times (Cowell/Kanter, 6/2).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mass spectrometry and glycobiology - what are the genetic applications?